Do you struggle with major depressive disorder (MDD)?

Contribute to a pivotal psychedelic drug research study that seeks to understand and improve the lives of those affected by major depressive disorder. We are looking for volunteers to participate in a research study with an investigational psychedelic study drug. Participation will last up to 64 weeks. During the study, all participants who meet eligibility requirements will have an opportunity to receive the investigational drug.

The uASPIRE study seeks to understand the potential of the study drug to re-wire the rigid patterns of activity in the brain that are associated with major depressive disorder and provide an alternative approach to currently available treatments for depression. If you think you may be eligible and are interested in advancing the knowledge of a psychedelic study drug, please complete the form and one of our staff members will reach out to you shortly.

Eligibility:

• You must be at least 18 years old and meet the DSM-5 criteria for a diagnosis of MDD.
• You are currently experiencing a major depressive episode of at least 60 days.
• You must be willing to stop taking all current depression medications during the study.
• You have not been diagnosed with uncontrolled diabetes mellitus.
• You are able and willing to adhere to trial requirements, including attending all trial visits and sessions and completing all trial evaluations.